Effects of concomitant glucocorticoids in TOZURA a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis

摘要

ObjectivesThis post hoc analysis of the TOZURA study programme evaluated the efficacy and safety of subcutaneous tocilizumab (TCZ-SC) as monotherapy or with concomitant conventional synthetic DMARDs (csDMARDs) in patients with RA categorized by baseline glucocorticoid (GC) use.